What is the optimal initial dose of epinephrine during neonatal resuscitation in the delivery room?


Journal

Journal of perinatology : official journal of the California Perinatal Association
ISSN: 1476-5543
Titre abrégé: J Perinatol
Pays: United States
ID NLM: 8501884

Informations de publication

Date de publication:
07 2021
Historique:
received: 01 12 2020
accepted: 25 02 2021
revised: 29 01 2021
pubmed: 14 3 2021
medline: 21 10 2021
entrez: 13 3 2021
Statut: ppublish

Résumé

The neonatal resuscitation program recommends a wide dose range of epinephrine for newborns who receive chest compressions (endotracheal tube [ET] dose of 0.05-0.1 mg/kg or intravenous [IV] dose of 0.01-0.03 mg/kg), which presents a challenge to neonatal care providers when attempting to determine the optimal initial dose. Dosing errors are common when preparing epinephrine for neonatal resuscitation. Based on animal data, we suggest preparing 0.1 mg/kg or 1 ml/kg of 1 mg/10 ml epinephrine in a 5 ml syringe for ET administration. For IV epinephrine, we suggest preparing an initial dose of 0.02 mg/kg or 0.2 ml/kg of 1 mg/10 ml epinephrine in a 1 ml syringe. A dose of 0.02 mg/kg enables use of a 1 ml syringe for a wide range of birth weights from 500 g to 5 kg. The use of a color-coded syringe may decrease errors in dose preparation.

Identifiants

pubmed: 33712718
doi: 10.1038/s41372-021-01032-7
pii: 10.1038/s41372-021-01032-7
doi:

Substances chimiques

Epinephrine YKH834O4BH

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1769-1773

Subventions

Organisme : U.S. Department of Health & Human Services | National Institutes of Health (NIH)
ID : HD096299
Organisme : U.S. Department of Health & Human Services | National Institutes of Health (NIH)
ID : HD072929

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Nature America, Inc.

Références

Redding JS, Pearson JW. Evaluation of drugs for cardiac resuscitation. Anesthesiology. 1963;24:203–7.
doi: 10.1097/00000542-196303000-00008
Weiner GM, Zaichkin J. Textbook of Neonatal Resuscitation (NRP). 7 ed. Elk Grove Village, IL: American Academy of Pediatrics; 2016. p. 326.
Barber CA, Wyckoff MH. Use and efficacy of endotracheal versus intravenous epinephrine during neonatal cardiopulmonary resuscitation in the delivery room. Pediatrics. 2006;118:1028–34.
doi: 10.1542/peds.2006-0416
Halling C, Sparks JE, Christie L, Wyckoff MH. Efficacy of Intravenous and Endotracheal Epinephrine during Neonatal Cardiopulmonary Resuscitation in the Delivery Room. J Pediatr. 2017;185:232–6.
Hudak ML. Epinephrine for Neonatal Resuscitation: the Limits of Knowledge. Pediatrics. 2020;146:e2020019968.
Isayama T, Mildenhall L, Schmölzer GM, Kim H-S, Rabi Y, Ziegler C, et al. The Route, Dose, and Interval of Epinephrine for Neonatal Resuscitation: a Systematic Review. Pediatrics. 2020;146:e20200586.
doi: 10.1542/peds.2020-0586
Halling C, Raymond T, Brown LS, Ades A, Foglia EE, Allen E, et al. Neonatal delivery room CPR: An analysis of the Get with the Guidelines®—Resuscitation Registry. Resuscitation. 2021;158:236–42.
Andersen LW, Berg KM, Saindon BZ, Massaro JM, Raymond TT, Berg RA, et al. Time to Epinephrine and Survival After Pediatric In-Hospital Cardiac Arrest. JAMA: J Am Med Assoc. 2015;314:802–10.
doi: 10.1001/jama.2015.9678
Lin YR, Li CJ, Huang CC, Lee TH, Chen TY, Yang MC, et al. Early Epinephrine Improves the Stabilization of Initial Post-resuscitation Hemodynamics in Children With Non-shockable Out-of-Hospital Cardiac Arrest. Front Pediatrics. 2019;7:220.
doi: 10.3389/fped.2019.00220
Lin YR, Wu MH, Chen TY, Syue YJ, Yang MC, Lee TH, et al. Time to epinephrine treatment is associated with the risk of mortality in children who achieve sustained ROSC after traumatic out-of-hospital cardiac arrest. Crit Care. 2019;23:101.
doi: 10.1186/s13054-019-2391-z
Fukuda T, Kondo Y, Hayashida K, Sekiguchi H, Kukita I. Time to epinephrine and survival after paediatric out-of-hospital cardiac arrest. Eur Heart J Cardiovasc Pharmacother. 2018;4:144–51.
doi: 10.1093/ehjcvp/pvx023
Maconochie IK, Aickin R, Hazinski MF, Atkins DL, Bingham R, Couto TB, et al. Pediatric Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Resuscitation. 2020;156:A120–A55.
doi: 10.1016/j.resuscitation.2020.09.013
Oliver G, Schäfer EA. The Physiological Effects of Extracts of the Suprarenal Capsules. J Physiol. 1895;18:230–76.
doi: 10.1113/jphysiol.1895.sp000564
Sobotka KS, Polglase GR, Schmolzer GM, Davis PG, Klingenberg C, Hooper SB. Effects of chest compressions on cardiovascular and cerebral hemodynamics in asphyxiated near-term lambs. Pediatr Res. 2015;78:395–400.
doi: 10.1038/pr.2015.117
Vali P, Chandrasekharan P, Rawat M, Gugino S, Koenigsknecht C, Helman J, et al. Evaluation of Timing and Route of Epinephrine in a Neonatal Model of Asphyxial Arrest. J Am Heart Assoc. 2017;6:e004402.
Vali P, Chandrasekharan P, Rawat M, Gugino S, Koenigsknecht C, Helman J, et al. Continuous Chest Compressions During Sustained Inflations in a Perinatal Asphyxial Cardiac Arrest Lamb Model. Pediatr Crit Care Med. 2017. 18:e370–7.
Sankaran D, Chandrasekharan PK, Gugino SF, Koenigsnecht C, Helman J, Nair J, et al. Randomised trial of epinephrine dose and flush volume in term newborn lambs. Archives of Disease in Childhood - Fetal and Neonatal Edition. Published Online First: 09 March 2021.
Vali P, Sankaran D, Rawat M, Berkelhamer S, Lakshminrusimha S. Epinephrine in Neonatal Resuscitation. Children (Basel). 2019;6.
Kaushal R, Bates DW, Landrigan C, McKenna KJ, Clapp MD, Federico F, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA. 2001;285:2114–20.
doi: 10.1001/jama.285.16.2114
Suresh G, Horbar JD, Plsek P, Gray J, Edwards WH, Shiono PH, et al. Voluntary anonymous reporting of medical errors for neonatal intensive care. Pediatrics. 2004;113:1609–18.
doi: 10.1542/peds.113.6.1609
Brune KD, Bhatt-Mehta V, Rooney DM, Weiner GM. Volume Versus Mass Dosing of Epinephrine for Neonatal Resuscitation: a Randomized Trial. Hosp Pediatr. 2019;9:757–62.
doi: 10.1542/hpeds.2019-0061
Brune KD, Bhatt-Mehta V, Rooney DM, Adams JT, Weiner GM. A Cognitive Aid for Neonatal Epinephrine Dosing. Hosp Pediatr. 2020;10:986–91.
doi: 10.1542/hpeds.2020-000299
Luten R, Wears RL, Broselow J, Croskerry P, Joseph MM, Frush K. Managing the unique size-related issues of pediatric resuscitation: reducing cognitive load with resuscitation aids. Acad Emerg Med. 2002;9:840–7.
doi: 10.1197/aemj.9.8.840
Nair J, Vali P, Gugino SF, Koenigsknecht C, Helman J, Nielsen LC, et al. Bioavailability of endotracheal epinephrine in an ovine model of neonatal resuscitation. Early Hum Dev. 2019;130:27–32.
doi: 10.1016/j.earlhumdev.2019.01.006
Stevens AD, Hernandez C, Jones S, Moreira ME, Blumen JR, Hopkins E, et al. Color-coded prefilled medication syringes decrease time to delivery and dosing errors in simulated prehospital pediatric resuscitations: a randomized crossover trial. Resuscitation. 2015;96:85–91.
doi: 10.1016/j.resuscitation.2015.07.035
Songstad NT, Klingenberg C, McGillick EV, Polglase GR, Zahra V, Schmölzer GM, et al. Efficacy of Intravenous, Endotracheal, or Nasal Adrenaline Administration During Resuscitation of Near-Term Asphyxiated Lambs. Front Pediatrics. 2020;8:262.

Auteurs

Payam Vali (P)

Department of Pediatrics, University of California, Davis, Sacramento, CA, USA. pvali@ucdavis.edu.

Gary M Weiner (GM)

Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, MI, USA.

Deepika Sankaran (D)

Department of Pediatrics, University of California, Davis, Sacramento, CA, USA.

Satyan Lakshminrusimha (S)

Department of Pediatrics, University of California, Davis, Sacramento, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH